HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly
The Health Resources and Services Administration (HRSA) is advising health care providers concerned about whether
…The Health Resources and Services Administration (HRSA) is advising health care providers concerned about whether
…Do 340B drug discounts induce hospitals to furnish more-expensive drugs to treat cancer than they otherwise would, raising patients’ coinsurance obligations and the cost of
…Editor’s note: The Medicare Payment Advisory Commission (MedPAC) is expected to report to Congress tomorrow that 340B’s effects on Medicare Part B beneficiaries’ cost sharing is likely small and varied across patients. We’ll publish an article about the findings and
…Groups representing 340B hospitals urged the White House yesterday to quash a planned survey due to
…The U.S. Justice Department is suing drug manufacturer Mallinckrodt for allegedly
…In theory, federal law and 340B program guidance should protect 340B entities from shouldering an unfair
…Editor’s Note: The 340B Report team is working hard on a special report on key developments from the 340B Coalition Winter Conference Feb. 10-12 in San Diego. We do not plan to publish this Thursday’s edition. Expect to see a detailed
…Drug manufacturers are doing a better job of providing the Health Resources and Services Administration (HRSA) with timely and accurate data needed to verify their 340B ceiling prices, the head of the federal 340B drug pricing program indicated today. Nonetheless,
…The Trump administration today asked Congress again to require 340B covered entities to report their 340B program savings and uses to the Health Resources and Services Administration (HRSA).
The administration made the request in its proposed federal budget for fiscal
…The Centers for Medicare & Medicaid Services (CMS) has taken another step toward requiring hospitals to let it see their 340B drug acquisition costs so CMS can base the hospitals’
…*Sign up for news summaries and alerts from 340B Report